Many of us have just assumed that RAC will be sold to BP from phase 2 onwards.
But perhaps not. Looking at this add & the other ongoing programs that we have not been informed of progress.....
Maybe RAC could instead become an incubator for promising molecules and Bisantrene be the first to be sold or licensed, giving the firm revenue for ongoing development & large divvies for shareholders... I'd be happy with that too !
General Comments / Chat, page-10411
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.055(3.62%) |
Mkt cap ! $268.4M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.56 | $106.0K | 67.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 649 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |